Y-mabs therapeutics, inc. (YMAB)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss

-26,179

-23,136

-23,922

-18,036

-15,934

-14,060

-11,426

-10,305

-7,483

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

86

79

48

20

19

-

-

-

-

Stock-based compensation

2,211

1,477

1,345

971

864

495

395

904

172

Foreign currency transactions

-25

80

-134

62

-51

4

-22

-62

-17

Changes in assets and liabilities:
Other current assets

-759

3,420

-1,627

267

-902

940

1,175

517

189

Other assets

11

51

74

1

56

-1

0

-4

192

Accounts payable

1,740

1,586

-1,984

3,149

-134

-439

2,068

-1,601

1,233

Accrued liabilities and other

-387

-1,034

1,431

186

805

1,356

919

-409

-166

NET CASH USED IN OPERATING ACTIVITIES

-21,756

-24,579

-21,395

-14,040

-13,483

-13,577

-9,188

-11,856

-6,608

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment

26

1,147

617

75

126

-

-

-

-

NET CASH USED IN INVESTING ACTIVITIES

-26

-1,147

-617

-75

-126

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercised stock options

370

-

-

-

-

-

-

-

-

Payment of offering costs for private placement

-

-

-

-

-

0

-766

127

1,641

NET CASH PROVIDED BY FINANCING ACTIVITIES

370

-

-

-

-

-1,842

102,373

-127

-1,641

Effect of exchange rates on cash, cash equivalents and restricted cash

50

-34

41

3

13

24

8

44

-20

NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

-21,362

108,944

-21,971

-14,112

-13,596

-15,452

93,140

-12,063

-8,269

SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES
Property and equipment purchases in accounts payable

-

-703

729

-65

88

-

-

-

-

Right-of-use assets obtained in exchange for lease obligations

-

0

69

-1,488

2,320

-

-

-

-

Deferred offering costs included in other assets and accounts payable and accrued liabilities and other

-

-

-

-

-

-

612

91

148